New Zealand markets close in 18 minutes

C4 Therapeutics, Inc. (CCCC)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.43-0.11 (-1.68%)
At close: 04:00PM EDT
6.69 +0.26 (+4.04%)
After hours: 07:46PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-132,493
-132,493
-128,175
-83,892
-66,335
Depreciation & amortisation
1,880
1,880
1,676
1,492
1,617
Stock-based compensation
27,235
27,235
30,016
21,512
3,432
Change in working capital
-6,938
-6,938
-16,779
-30,090
-13,177
Accounts receivable
-10,327
-10,327
4,244
-1,232
139
Accounts payable
273
273
-3,333
-1,179
467
Other working capital
-108,546
-108,546
-111,435
-88,242
-67,899
Other non-cash items
6,641
6,641
6,609
2,134
1,633
Net cash provided by operating activities
-106,838
-106,838
-105,939
-86,965
-67,249
Cash flows from investing activities
Investments in property, plant and equipment
-1,708
-1,708
-5,496
-1,277
-650
Purchases of investments
-129,898
-129,898
-219,527
-537,740
-293,855
Sales/maturities of investments
289,955
289,955
283,445
349,681
104,000
Net cash used for investing activities
158,349
158,349
58,422
-189,336
-190,505
Cash flows from financing activities
Debt repayment
-12,500
-12,500
0
-
-
Common stock issued
57,673
57,673
0
169,465
340,599
Common stock repurchased
-110
-110
0
0
-194
Other financing activities
368
368
370
-395
-3,606
Net cash used provided by (used for) financing activities
45,489
45,489
1,147
171,400
348,932
Net change in cash
97,000
97,000
-46,370
-104,901
91,178
Cash at beginning of period
33,033
33,033
79,403
184,304
93,126
Cash at end of period
130,033
130,033
33,033
79,403
184,304
Free cash flow
Operating cash flow
-106,838
-106,838
-105,939
-86,965
-67,249
Capital expenditure
-1,708
-1,708
-5,496
-1,277
-650
Free cash flow
-108,546
-108,546
-111,435
-88,242
-67,899